info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143859 |
| CAS No | NA |
| Mol.F. | C613CH5D2ClN215N2O5S2 |
| Mol.Wt. | 331.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143860 |
| CAS No | NA |
| Mol.F. | C613CH5D2ClN4O5S2 |
| Mol.Wt. | 329.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143861 |
| CAS No | NA |
| Mol.F. | C31H43N3O6S |
| Mol.Wt. | 585.76 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143862 |
| CAS No | NA |
| Mol.F. | C31H45N3O6S |
| Mol.Wt. | 587.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143863 |
| CAS No | NA |
| Mol.F. | C21H22N2O8S2 |
| Mol.Wt. | 494.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143864 |
| CAS No | NA |
| Mol.F. | C31H43N3O7S |
| Mol.Wt. | 601.76 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143865 |
| CAS No | NA |
| Mol.F. | C14H17BrN2O4 |
| Mol.Wt. | 357.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143866 |
| CAS No | NA |
| Mol.F. | C26H35N3O4 |
| Mol.Wt. | 453.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143867 |
| CAS No | NA |
| Mol.F. | C13H16N2O4S |
| Mol.Wt. | 296.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143868 |
| CAS No | NA |
| Mol.F. | C12H14FN3O6 |
| Mol.Wt. | 315.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143869 |
| CAS No | NA |
| Mol.F. | C21H38N8O13 : X(H2SO4) |
| Mol.Wt. | 610.6 : X(98.1) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143870 |
| CAS No | NA |
| Mol.F. | C8H17N7O5 |
| Mol.Wt. | 291.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143871 |
| CAS No | NA |
| Mol.F. | C27H50N8O18 |
| Mol.Wt. | 774.74 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143872 |
| CAS No | NA |
| Mol.F. | C21H40N8O12 |
| Mol.Wt. | 596.60 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143873 |
| CAS No | NA |
| Mol.F. | C17H19D3N2O2 |
| Mol.Wt. | 289.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143874 |
| CAS No | 19023-41-7 |
| Mol.F. | C11H16N2O |
| Mol.Wt. | 192.3 g/mole |
| INV STATUS | In Stock |
